Search Results Search Sort by RelevanceMost Recent Policy Forum Dec 2005 Physician-Advocate: Deciding What To Fight for and When Philip A. Pizzo, MD Virtual Mentor. 2005;7(12):813-815. doi: 10.1001/virtualmentor.2005.7.12.pfor2-0512. Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 1 Marion Danis, MD Virtual Mentor. 2004;6(1):6-8. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401. Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 2 Leonard M. Fleck, PhD Virtual Mentor. 2004;6(1):9-11. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.
Policy Forum Dec 2005 Physician-Advocate: Deciding What To Fight for and When Philip A. Pizzo, MD Virtual Mentor. 2005;7(12):813-815. doi: 10.1001/virtualmentor.2005.7.12.pfor2-0512.
Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 1 Marion Danis, MD Virtual Mentor. 2004;6(1):6-8. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401.
Case and Commentary Jan 2004 Campaign Posters in the Clinic, Commentary 2 Leonard M. Fleck, PhD Virtual Mentor. 2004;6(1):9-11. doi: 10.1001/virtualmentor.2004.6.1.ccas1-0401.
History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.